Shares Outstanding for Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported diluted shares outstanding is 107.50M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
107.50M
YoY change
-5.6%
5Y CAGR
-1.2%
Peak year (2016)
116.30M
Latest annual
108.60M
Shares Outstanding history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
Shares Outstanding history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 108.60M | -5.6% | ||
| 2024 | 115.10M | +1.2% | ||
| 2023 | 113.70M | +0.2% | ||
| 2022 | 113.50M | +1.2% | ||
| 2021 | 112.20M | -2.5% | ||
| 2020 | 115.10M | +0.4% | ||
| 2019 | 114.60M | -0.2% | ||
| 2018 | 114.80M | -1.0% | ||
| 2017 | 115.91M | -0.3% | ||
| 2016 | 116.30M | +0.9% | ||
| 2015 | 115.23M | +1.6% | ||
| 2014 | 113.47M | +2.0% | ||
| 2013 | 111.29M | -3.5% | ||
| 2012 | 115.38M | +27.3% | ||
| 2011 | 90.61M | +9.3% | ||
| 2010 | 82.93M | +3.9% | ||
| 2009 | 79.78M | +1.2% | ||
| 2008 | 78.83M | +18.8% | ||
| 2007 | 66.33M | +14.4% | ||
| 2006 | 57.97M | +3.6% | ||
| 2005 | 55.95M | -0.4% | ||
| 2004 | 56.17M | +11.3% | ||
| 2003 | 50.45M | +14.8% | ||
| 2002 | 43.95M | +4.4% | ||
| 2001 | 42.09M | +19.7% | ||
| 2000 | 35.17M | +11.8% | ||
| 1999 | 31.45M | +1.4% | ||
| 1998 | 31.00M | +6.9% | ||
| 1997 | 29.00M | +18.5% | ||
| 1996 | 24.46M | +23.9% | ||
| 1995 | 19.75M | +4.2% | ||
| 1994 | 18.95M | +14.5% | ||
| 1993 | 16.56M | +7.5% | ||
| 1992 | 15.40M | -0.7% | ||
| 1991 | 15.52M | +1.0% | ||
| 1990 | 15.36M | — |
Shares Outstanding values are taken from Regeneron Pharmaceuticals's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Regeneron Pharmaceuticals (REGN) diluted shares outstanding is 108.60M – declined 5.6% year-over-year.
Regeneron Pharmaceuticals diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is -1.2%, with a net decline across the window.
Regeneron Pharmaceuticals diluted shares outstanding peaked at 116.30M in 2016; the latest annual figure is 108.60M in 2025 (6.6% below peak).
2016 marks the peak diluted shares outstanding at 116.30M, with the historical low of 15.36M recorded in 1990.
Within Healthcare, Regeneron Pharmaceuticals (REGN) ranks 9th among 8 peers we track. The peer median for diluted shares outstanding is 1.34B.
Regeneron Pharmaceuticals Shares Outstanding by Year
Regeneron Pharmaceuticals Shares Outstanding 2025: 108.60M
Regeneron Pharmaceuticals diluted shares outstanding in 2025 was 108.60M, declined 5.6% below 2024.
Regeneron Pharmaceuticals Shares Outstanding 2024: 115.10M
Regeneron Pharmaceuticals diluted shares outstanding in 2024 was 115.10M, edged up 1.2% from 2023.
Regeneron Pharmaceuticals Shares Outstanding 2023: 113.70M
Regeneron Pharmaceuticals diluted shares outstanding in 2023 was 113.70M, edged up 0.2% from 2022.
Regeneron Pharmaceuticals Shares Outstanding 2022: 113.50M
Regeneron Pharmaceuticals diluted shares outstanding in 2022 was 113.50M, edged up 1.2% from 2021.
Regeneron Pharmaceuticals Shares Outstanding 2021: 112.20M
Regeneron Pharmaceuticals diluted shares outstanding in 2021 was 112.20M.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers — Shares Outstanding
Companies in the same sector as Regeneron Pharmaceuticals, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Regeneron Pharmaceuticals's diluted shares outstanding?
- Latest reported diluted shares outstanding for Regeneron Pharmaceuticals (REGN) is 107.50M (period ending December 31, 2025).
How has Regeneron Pharmaceuticals diluted shares outstanding changed year-over-year?
- Regeneron Pharmaceuticals (REGN) diluted shares outstanding changed -5.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Regeneron Pharmaceuticals diluted shares outstanding?
- Regeneron Pharmaceuticals (REGN) diluted shares outstanding compound annual growth rate is -1.2% over the most recent 5 years available.
When did Regeneron Pharmaceuticals diluted shares outstanding hit its highest annual value?
- Regeneron Pharmaceuticals diluted shares outstanding reached its highest annual value of 116.30M in 2016.
What was Regeneron Pharmaceuticals diluted shares outstanding in 2024?
- Regeneron Pharmaceuticals (REGN) diluted shares outstanding in 2024 was 115.10M.
What was Regeneron Pharmaceuticals diluted shares outstanding in 2025?
- Regeneron Pharmaceuticals (REGN) diluted shares outstanding in 2025 was 108.60M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
REGN Overview
Company profile, financial tools, and key metrics
REGN Revenue Counter
Earns $454.81 every second. See per minute, hour, and day.
REGN Earnings Counter
Earns $142.85 per second net profit. See per minute, hour, and day.
REGN Economic Scale
Exceeds Rwanda's GDP. Compare with world economies.
REGN What If Invested
What if you had invested $1,000? See historical returns from any date.
REGN How It Makes Money
Discover visual breakdown of $14.34B in revenue — where it comes from and where it goes.
REGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
REGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
REGN Daily Price Character
Explosive · 47.1% historical win rate (green days). Streaks & record days.
REGN Buybacks
4.33% TTM buyback yield. Shareholder yield & SBC comparison.
REGN Dividend Profile
Yield: 0.52%. See full history.
REGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
REGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.